JMF
UBX

Johnson Midwest Financial’s Unity Biotechnology UBX Stock Holding History

Johnson Midwest Financial’s Portfolio UBX Stock Details UBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$1.59K Hold
661
– – ﹤0.01% 329
2023
Q2 		$1.69K Hold
661
– – ﹤0.01% 323
2023
Q1 		$1.08K Hold
661
– – ﹤0.01% 351
2022
Q4 		$2K Hold
661
– – 0.01% 336
2022
Q3 		$3 Buy
661
+51
+8% +$322 0.01% 278
2022
Q2 		$3K Buy
+610
New +$5.09K ﹤0.01% 255

Other funds holding UBX

AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MC
Mayo Clinic Rochester, Minnesota $2.9M AUM 14.49% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
FFVM
Founders Fund V Management San Francisco, California $2.16M AUM 77.37% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Johnson Midwest Financial's UBX Position: Q3 2023 in Review

Johnson Midwest Financial held its Unity Biotechnology (UBX) position steady in Q3 2023 at 661 shares worth $1.59K. The position accounts for ﹤0.01% of the portfolio, ranked #329.

Johnson Midwest Financial first reported a position in UBX in Q2 2022 and has held it in 6 quarters since. The position peaked at $3K in Q2 2022. 36 funds tracked by Wall St. Rank hold UBX as of Q3 2023.

  • Johnson Midwest Financial held 661 shares of Unity Biotechnology worth $1.59K as of Q3 2023.
  • Johnson Midwest Financial left its Unity Biotechnology share count unchanged in Q3 2023.
  • Unity Biotechnology made up ﹤0.01% of Johnson Midwest Financial's portfolio in Q3 2023, its #329 holding.
  • Johnson Midwest Financial first reported a position in Unity Biotechnology in Q2 2022 and has held it in 6 quarters since.
  • Johnson Midwest Financial's Unity Biotechnology position peaked at $3K in Q2 2022.
  • 36 funds tracked by Wall St. Rank held Unity Biotechnology as of Q3 2023.

Based on Johnson Midwest Financial's 13F filing for Q3 2023, filed 7 Nov 2023.